SCHEMBL5147496

SCHEMBL5147496

O=CCc1sccc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2562150 0.79 ADRA1D (0.38)
SCHEMBL1205997 0.78
SCHEMBL31467964 0.76
SCHEMBL1696338 0.74
SCHEMBL29137771 0.74
SCHEMBL1823076 0.74
SCHEMBL1295553 0.74
SCHEMBL28047104 0.74 ADRA1D (0.37)
SCHEMBL10947172 0.72
SCHEMBL15009038 0.71 KEAP1 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114249667-B Method for preparing N-H ketoamide by two-step one-pot reaction catalyzed by tert-butyl alcohol salt 衡阳师范学院 2023-12-26 CN disclosed
EP-2723739-A1 SUBSTITUTED 6-AZA-ISOINDOLIN-1-ONE DERIVATIVES Takeda Pharmaceutical Company Limited (JP) 2014-04-30 EP disclosed
WO-2012177714-A1 SUBSTITUTED 6-AZA-ISOINDOLIN-1-ONE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-12-27 WO disclosed
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed